Health
BioNTech/Pfizer Vaccination Analysis Confirms High Overall Efficacy – Clinical OMICs News
Results from an analysis of COVID-19 vaccination data from Israel show over 90% protection from SARS-CoV-2 infection with the BioNTech/Pfizer vaccine. However,…
Results from an analysis of COVID-19 vaccination data from Israel, where most of the population have now been vaccinated, confirm earlier Phase III data and show over 90% protection from asymptomatic and symptomatic disease with the BioNTech/Pfizer vaccine.
Notably, this efficacy held true despite several variants of concern circulating in Israel at the time of vaccination, with the UK B.1.1.7 variant being the most common. While efficacy was good, there was a decrease in efficacy in much older…
-
General15 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General18 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News17 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business15 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher